Literature DB >> 9919097

Individually reported effectiveness of therapy for chronic pain.

M Donovan1, K D Laack.   

Abstract

In 1996, a primary care-based multidisciplinary group model for treating patients with chronic pain was begun in a large HMO. Prior to the visits, patients completed an assessment, which included their description of previous and current therapies and their effectiveness (inventory developed by A. G. Lipman). This article describes the reports of the first 163 patients. Females were referred three times more often than males; the average age was 52 (range 18 to 88); average years in pain = 11 (range 0.3-50). Most patients reported more than one source of pain. No therapy was reported to be effective for everyone; what was highly effective for one could actually increase pain in another. Side effects caused patients to discontinue even effective therapy. Costly does not mean more effective. It is, therefore, essential that a systematic process of accessment, evaluation, and titration be employed with every intervention.

Entities:  

Mesh:

Year:  1998        PMID: 9919097     DOI: 10.1177/105477389800700408

Source DB:  PubMed          Journal:  Clin Nurs Res        ISSN: 1054-7738            Impact factor:   2.075


  3 in total

1.  Feasibility of a patient-controlled cognitive-behavioral intervention for pain, fatigue, and sleep disturbance in cancer.

Authors:  Kristine L Kwekkeboom; Kristen Abbott-Anderson; Britt Wanta
Journal:  Oncol Nurs Forum       Date:  2010-05       Impact factor: 2.172

2.  Individual difference variables and the effects of progressive muscle relaxation and analgesic imagery interventions on cancer pain.

Authors:  Kristine L Kwekkeboom; Britt Wanta; Molly Bumpus
Journal:  J Pain Symptom Manage       Date:  2008-05-27       Impact factor: 3.612

3.  Patients' perceptions of the effectiveness of guided imagery and progressive muscle relaxation interventions used for cancer pain.

Authors:  Kristine L Kwekkeboom; Hannah Hau; Britt Wanta; Molly Bumpus
Journal:  Complement Ther Clin Pract       Date:  2008-06-19       Impact factor: 2.446

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.